Breast Cancer Testing at CENTOGENE
Thinking about tomorrow, today.
Caring for people through reliable genetic testing. Helping your patients and their families to make decisions about their therapy and screening options.
CENTOGENE is a global leader in the diagnosis of rare genetic diseases and holds multiple international accreditations (ISO, CAP, CLIA), meeting the highest standards for diagnostic testing and reporting. Our experience combined with our scienti c expertise and medical competence allows the application of state-of-the-art technologies and the development of a unique, multi-ethnic mutation database, CentoMD®.
Download the full pdf from here